PRINCIPAL DISPLAY PANEL — 5 g Tube Carton
(mirtazapine transdermal ointment)
For Topical Application in Cats Only. Not for oral or ophthalmic use.
Indication: For the management of weight loss in cats.
Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Each tube contains 100 mg mirtazapine.
Approved by FDA under NADA # 141-481
Net wt.: 5 g
| MIRATAZ |
|Product Information |
|Product Type ||PRESCRIPTION ANIMAL DRUG ||Item Code (Source) ||NDC:17033-060 |
|Route of Administration ||TOPICAL ||DEA Schedule || |
|Active Ingredient/Active Moiety |
|Ingredient Name ||Basis of Strength ||Strength |
|Mirtazapine (Mirtazapine) ||Mirtazapine ||20 mg in 1 g |
|Inactive Ingredients |
|Ingredient Name ||Strength |
| Polyethylene glycol 400 || |
| Polyethylene glycol 3350 || |
| Diethylene glycol monoethyl ether || |
| CAPRYLOCAPROYL POLYOXYLGLYCERIDES 8 || |
| Oleyl alcohol || |
| BUTYLATED HYDROXYTOLUENE || |
| DIMETHICONE || |
| STARCH, TAPIOCA || |
| POLYMETHYLSILSESQUIOXANE (11 MICRONS) || |
|Product Characteristics |
|Color ||WHITE (white to off-white) ||Score || |
|Shape || ||Size || |
|Flavor || ||Imprint Code || |
|Contains || |
|# ||Item Code ||Package Description ||Multilevel Packaging |
| 1 ||NDC:17033-060-05 ||1 TUBE in 1 CARTON ||contains a TUBE |
| 1 || ||5 g in 1 TUBE ||This package is contained within the CARTON (17033-060-05) |
| Marketing Information |
|Marketing Category ||Application Number or Monograph Citation ||Marketing Start Date ||Marketing End Date |
|NADA ||NADA141481 ||07/08/2018 || |
|Labeler — Dechra Veterinary Products
Revised: 02/2021 Dechra Veterinary Products
VetLabel.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by VetLabel.com. Every individual animal healthcare product label entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.